Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dihydroartemisinin-Piperaquine vs Artemether-Lumefantrine for Uncomplicated Malaria
NCT01075945Phase 4Unknown
- Sponsor
- University of Khartoum
- Start
- Feb 2010
- Primary completion
- Apr 2010
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dihydroartemisinin + piperaquine in malaria, sponsored by University of Khartoum. Status: unknown.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01075945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01075945.